Want to see KEQU full AI Analyst Report?
KEQU Stock Chart & Stats
$38.35
-$1.41(-2.31%)
At close: 4:00 PM EST
$38.35
-$1.41(-2.31%)
Day’s Range― - ―
52-Week Range$33.27 - $60.89
Previous CloseN/A
Volume12.17K
Average Volume (3M)8.77K
Market Cap
$105.04M
Enterprise Value$129.95M
Total Cash (Recent Filing)$11.62M
Total Debt (Recent Filing)$30.18M
Price to Earnings (P/E)11.0
Beta0.90
Next Earnings
Sep 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.35
Shares Outstanding2,870,410
10 Day Avg. Volume10,539
30 Day Avg. Volume8,774
Financial Highlights & Ratios
PEG Ratio-0.71
Price to Book (P/B)1.42
Price to Sales (P/S)0.38
P/FCF Ratio7.21
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit1.62
Enterprise Value/Ebitda5.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Margin ExpansionGross margin expansion to roughly 28% reflects sustained improvements in pricing, product mix, and operational execution versus the mid-teens in 2022. Higher structural margins support durable profitability across project cycles and give the company margin headroom to absorb cost inflation or invest in growth initiatives.
Profitability & ROEThe company moved from loss-making to consistent operating profitability and has expanded equity with strong ROE in recent years. That persistent ability to generate attractive returns on capital signals competent resource allocation and enhances capacity to fund organic growth and future acquisitions over the medium term.
Strategic Acquisition & FootprintIntegration of Nu Aire and an expanded global footprint (manufacturing in North Carolina and India plus international partnerships) broadens product set and geographic channels. This structural diversification strengthens market position in life sciences and institutional lab fit-outs, supporting more stable revenue streams over time.
Bears Say
Weak Cash ConversionZero operating and free cash flow despite reported earnings in 2026 TTM indicates poor cash conversion and working-capital stress. Over time this constrains the company’s ability to fund operations, capex, dividends, or debt servicing without external financing, raising execution risk during slower demand periods.
Elevated LeverageMaterially higher debt versus the low-debt 2024 position reduces financial flexibility. With debt around 75% of equity, interest and covenant risk rise and maneuverability for opportunistic investments or to absorb demand shocks is limited—particularly problematic given weak recent cash generation.
Revenue VolatilityRevenue shows inconsistency tied to timing of large lab projects and end-market capex cycles. The recent dip and compressed net margin in 2026 TTM highlight sensitivity to demand and project timing, making top-line and earnings visibility weaker and complicating medium-term planning and consistent cash flow generation.
Kewaunee Scientific News
KEQU FAQ
What was Kewaunee Scientific Corp.’s price range in the past 12 months?
Kewaunee Scientific Corp. lowest stock price was $33.27 and its highest was $60.89 in the past 12 months.
What is Kewaunee Scientific Corp.’s market cap?
Kewaunee Scientific Corp.’s market cap is $105.04M.
When is Kewaunee Scientific Corp.’s upcoming earnings report date?
Kewaunee Scientific Corp.’s upcoming earnings report date is Sep 03, 2026 which is in 53 days.
How were Kewaunee Scientific Corp.’s earnings last quarter?
Kewaunee Scientific Corp. released its earnings results on Jun 23, 2026. The company reported $1.131 earnings per share for the quarter, beating the consensus estimate of N/A by $1.131.
Is Kewaunee Scientific Corp. overvalued?
According to Wall Street analysts Kewaunee Scientific Corp.’s price is currently Overvalued.
Does Kewaunee Scientific Corp. pay dividends?
Kewaunee Scientific Corp. pays a Quarterly dividend of $0.19 which represents an annual dividend yield of N/A. See more information on Kewaunee Scientific Corp. dividends here
What is Kewaunee Scientific Corp.’s EPS estimate?
Kewaunee Scientific Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kewaunee Scientific Corp. have?
Kewaunee Scientific Corp. has 2,870,410 shares outstanding.
What happened to Kewaunee Scientific Corp.’s price movement after its last earnings report?
Kewaunee Scientific Corp. reported an EPS of $1.131 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.623%.
Which hedge fund is a major shareholder of Kewaunee Scientific Corp.?
Currently, no hedge funds are holding shares in KEQU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kewaunee Scientific Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
KEQU Sentiment 100%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Increased
By 2.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.05%
12-Months-Change
Fundamentals
Return on Equity
16.29%
Trailing 12-Months
Asset Growth
-8.40%
Trailing 12-Months
Company Description
Kewaunee Scientific Corp.
Kewaunee Scientific Corporation, established in 1906 and based in Statesville, North Carolina, specializes in providing custom furniture and infrastructure systems for scientific, medical, and technical settings. The company manages its operations through distinct domestic and international divisions. Its extensive product line features diverse furniture options crafted from steel, wood, and laminate, along with specialized equipment like fume hoods, biological safety cabinets, laminar flow systems, and ductless hoods. Kewaunee also offers versatile modular and column systems, mobile workstations, carts, durable epoxy resin worksurfaces, sinks, and various accessories, all supported by comprehensive design assistance. These solutions serve a broad client base: Laboratory products are essential for chemistry, physics, biology, and other general science research conducted in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, governmental, and healthcare industries. Technical products are utilized in facilities manufacturing computers and light electronics, as well as by those requiring furniture for computer and networking setups. Laminate casework applications extend to educational, healthcare, and industrial environments. The corporation primarily distributes its offerings through a network of independent dealers, its own subsidiary companies, and a major national distributor.
Technical Analysis
Ownership Overview
6.47% Insiders
11.21% Mutual Funds
13.69% Other Institutional Investors
60.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---